LXRX - LEXICON PHARMACEUTICALS, INC.

QQQ $ 446.25 $ -12.35 (-2.68 %)

DIA $ 404.28 $ -3.99 (-0.98 %)

SPY $ 539.90 $ -9.25 (-1.68 %)

TLT $ 99.49 $ -0.01 (-0.01 %)

GLD $ 230.65 $ -1.72 (-0.74 %)

Previous Close

$ 1.61

Open

Bid

$ 1.60 x 4,000

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.92 - $ 3.73

Volume

3,455,953

Average Volume

Market Cap

582M

Beta (5Y Monthly)

$ 0.88

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-02-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	03-25-2024	12-31-2023	10-K
4	11-08-2023	09-30-2023	10-Q
5	08-04-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	03-03-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-03-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	03-10-2022	12-31-2021	10-K
12	11-09-2021	09-30-2021	10-Q
13	08-06-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	03-12-2021	12-31-2020	10-K
16	10-30-2020	09-30-2020	10-Q
17	07-29-2020	06-30-2020	10-Q
18	04-27-2020	03-31-2020	10-Q
19	03-12-2020	12-31-2019	10-K
20	11-07-2019	09-30-2019	10-Q
21	08-01-2019	06-30-2019	10-Q
22	05-01-2019	03-31-2019	10-Q
23	03-15-2019	12-31-2018	10-K
24	11-01-2018	09-30-2018	10-Q
25	07-30-2018	06-30-2018	10-Q
26	05-03-2018	03-31-2018	10-Q
27	03-01-2018	12-31-2017	10-K
28	11-08-2017	09-30-2017	10-Q
29	08-01-2017	06-30-2017	10-Q
30	05-04-2017	03-31-2017	10-Q
31	03-06-2017	12-31-2016	10-K
32	11-07-2016	09-30-2016	10-Q
33	08-04-2016	06-30-2016	10-Q
34	05-05-2016	03-31-2016	10-Q
35	03-11-2016	12-31-2015	10-K
36	11-09-2015	09-30-2015	10-Q
37	08-07-2015	06-30-2015	10-Q
38	05-05-2015	03-31-2015	10-Q
39	03-12-2015	12-31-2014	10-K
40	11-06-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

The Analyst Verdict: Lexicon Pharmaceutica...
09/03/2024 19:00:50

HC Wainwright & Co. Reiterates Buy on Lexi...
09/03/2024 16:13:37

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy and maintains $...

Lexicon Pharmaceuticals' New Secondary Ana...
09/03/2024 12:20:45

Results showed reductions in heart attack, stroke and heart failure events in all patients with even greater benefit for heart ...

HC Wainwright & Co. Reiterates Buy on Lexi...
08/21/2024 16:42:17

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy and maintains $...

Lexicon Pharmaceuticals FDA Advisory Commi...
08/21/2024 12:06:50

Advisory Committee Meeting Scheduled for October 31, 2024; PDUFA Goal Date Remains December 20, 2024 Lexicon Seeks Approval for...

Analyst Scoreboard: 6 Ratings For Lexicon ...
08/13/2024 20:00:34

HC Wainwright & Co. Reiterates Buy on Lexi...
08/13/2024 18:31:17

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy and maintains $...

Lexicon Pharmaceuticals Refocuses Resource...
08/13/2024 12:39:41

Lexicon Pharmaceuticals To Present Three P...
08/07/2024 12:16:18

5 Analysts Have This To Say About Lexicon ...
08/02/2024 18:09:05

HC Wainwright & Co. Reiterates Buy on Lexi...
08/02/2024 12:22:17

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy and maintains $...

why-doordash-shares-are-trading-higher-by-10-here-are-20-stocks-moving-premarket

Why DoorDash Shares Are Trading Higher By ...
08/02/2024 12:15:41

intel-reports-weak-results-joins-amazon-opendoor-technologies-and-other-big-stocks-moving-lower-in-fridays-pre-market-session

Intel Reports Weak Results, Joins Amazon, ...
08/02/2024 10:01:13

Lexicon Pharmaceuticals Q2 2024 GAAP EPS $...
08/01/2024 20:02:29

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate ...

HC Wainwright & Co. Reiterates Buy on Lexi...
07/16/2024 17:30:13

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy and maintains $...

Lexicon Pharmaceuticals Receives Dec. 20, ...
07/16/2024 12:06:18

Lexicon Pharmaceuticals Announces New Anal...
07/15/2024 12:07:35

Lexicon Appoints Mike Exton As New Chief E...
07/08/2024 13:21:07

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that the Lexicon Board of Directors has appointed Mike Exton, Ph.D....

HC Wainwright & Co. Reiterates Buy on Lexi...
06/24/2024 10:36:16

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy and maintains $...

HC Wainwright & Co. Reiterates Buy on Lexi...
06/21/2024 14:15:03

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy and maintains $...